Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Clinical and Molecular Hepatology. 2023;29(2):371-373 
Changing Nomenclature from Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Fatty Liver Disease – Not Only Premature But Also Confusing
Journal of Clinical and Experimental Hepatology. 2021;11(2):278-279
The Shift from nonalcoholic fatty liver disease to metabolic dysfunction–associated fatty liver disease
Clinical Liver Disease. 2022;20(5):157-161
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease
Nephrology Dialysis Transplantation. 2022;38(3):700-711
1167-P: Nonalcoholic Fatty Liver Disease, Metabolic Dysfunction Associated Fatty Liver Disease, and Associations with All-Cause and Cause-Specific Mortality
Diabetes. 2021;70(Supplement_1):
From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
Journal of Clinical Medicine. 2021;10(5):924
Metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease: Which can better identify the populations with a high risk of cardiovascular disease?
Hepatology Research. 2021;51(11):1097-1099
Letter to the Editor: Nonalcoholic Fatty Liver Disease Without Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome
Clinical Gastroenterology and Hepatology. 2022;
Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
. 2021;
Renaming from nonalcoholic fatty liver disease to metabolism dysfunction associated fatty liver disease: Pros and cons
Hepatology Research. 2022;52(5):415-416